Valuing Pharmaceutical Companies: A Guide to the Assessment and Evaluation of Assets, Performance and Prospects

Author:   Karen Beynon ,  Andrew Porter
Publisher:   Elsevier Science & Technology
ISBN:  

9781855734586


Pages:   192
Publication Date:   19 June 2000
Format:   Hardback
Availability:   Out of stock   Availability explained


Our Price $673.20 Quantity:  
Add to Cart

Share |

Valuing Pharmaceutical Companies: A Guide to the Assessment and Evaluation of Assets, Performance and Prospects


Add your own review!

Overview

Full Product Details

Author:   Karen Beynon ,  Andrew Porter
Publisher:   Elsevier Science & Technology
Imprint:   Woodhead Publishing Ltd
Dimensions:   Width: 15.60cm , Height: 1.70cm , Length: 23.40cm
Weight:   0.500kg
ISBN:  

9781855734586


ISBN 10:   1855734583
Pages:   192
Publication Date:   19 June 2000
Audience:   General/trade ,  General
Format:   Hardback
Publisher's Status:   Unknown
Availability:   Out of stock   Availability explained

Table of Contents

Part 1 The global pharmaceutical industry: Pharmaceuticals and the treatment of disease; Structure and internationalisation of the industry; Regional and national developments; Major changes in the pharmaceutical industry. Part 2 Analysis and evaluation of pharmaceutical companies: Valuing major quoted pharmaceutical companies; Valuing biotechnology companies and new venture financing; The assessment of research and development; The assessment of product sales potential. Part 3 Pharmaceutical equity trading: Key issues influencing pharmaceutical share price movement; Investment and trading strategy; Dealing in major equity markets.

Reviews

Author Information

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions
Latest Reading Guide

Aorrng

Shopping Cart
Your cart is empty
Shopping cart
Mailing List